Clinical applications of cytokinesPESCHEL, C; HUBER, C; AULITZKY, W. E et al.La Presse médicale (1983). 1994, Vol 23, Num 23, pp 1083-1091, issn 0755-4982Article

Cytokine therapy of neoplastic and inflammatory diseaseAULITZKY, W. E; HUBER, C; PESCHEL, C et al.International archives of allergy and immunology. 1993, Vol 101, Num 3, pp 221-226, issn 1018-2438Article

Interleukins : clinical pharmacology and therapeutic useAULITZKY, W. E; SCHULER, M; PESCHEL, C et al.Drugs (Basel). 1994, Vol 48, Num 5, pp 667-677, issn 0012-6667Article

Biotherapy of chronic myelogenous leukemiaAULITZKY, W. E; PESCHEL, C; SCHNELLER, F et al.Annals of hematology (Print). 1995, Vol 70, Num 3, pp 113-120, issn 0939-5555Article

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantationHENKES, M; MARTIN, S; EINSELE, H et al.Annals of hematology (Print). 2002, Vol 81, Num 6, pp 343-346, issn 0939-5555Article

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantationKOLBE, K; DOMKIN, D; DERIGS, H. G et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 2, pp 143-147, issn 0268-3369Article

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P)HLADIK, F; KOLBE, K; IRSCHICK, E. U et al.Annals of hematology (Print). 1993, Vol 67, Num 2, pp 67-74, issn 0939-5555Article

Role of ondansetron plus dexamethasone in fractionated chemotherapyRÄTH, U; UPADHYAYA, B. K; WEISSBACH, L et al.Oncology. 1993, Vol 50, Num 3, pp 168-172, issn 0030-2414Conference Paper

Treatment of cancer patients with recombinant interferon-γ induces release of endogenous tumor necrosis factor-αAULITZKY, W. E; AULITZKY, W. K; FRICK, J et al.Immunobiology (1979). 1990, Vol 180, Num 4-5, pp 385-394, issn 0171-2985, 10 p.Article

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas: a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkMROSS, K; DITTRICH, C; SCHEULEN, M. E et al.British journal of cancer. 2012, Vol 107, Num 2, pp 280-286, issn 0007-0920, 7 p.Article

Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factorsJONILET, T; PESCHEL, C; SCHWAB, R et al.British journal of haematology. 1998, Vol 100, Num 2, pp 295-303, issn 0007-1048Article

Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and plateletsWALLERATH, T; GATH, I; AULITZKY, W. E et al.Thrombosis and haemostasis. 1997, Vol 77, Num 1, pp 163-167, issn 0340-6245Article

Neopterin excretion after liver transplantation and its value in differential diagnosis of complicationsTILG, H; VOGEL, W; AULITZKY, W. E et al.Transplantation. 1989, Vol 48, Num 4, pp 594-599, issn 0041-1337, 6 p.Article

Enhanced serum levels of β-2-microglobulin neopterin, and interferon-γ in patients treated with recombinant tumor necrosis factor-αAULITZKY, W. E; TILG, H; PICHLER, E et al.Journal of interferon research. 1988, Vol 8, Num 5, pp 655-664, issn 0197-8357Article

Interferon-γ for the treatement of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responsesAULITZKY, W; GASTL, G; AULITZKY, W. E et al.Immunobiology (1979). 1987, Vol 176, Num 1-2, pp 85-95, issn 0171-2985Article

Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolismBUSSE, D; BUSCH, F. W; SCHWEIZER, E et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 263-268, issn 0344-5704Article

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer : Results of a phase II studySCHULER, M; BRUNTSCH, U; SPÄTH-SCHWALBE, E et al.European journal of cancer (1990). 1998, Vol 34, Num 5, pp 754-756, issn 0959-8049Article

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy : Toxicity, pharmacokinetics, and biological effectsLORENZ, J; WILHELM, K; KESSLER, M et al.Clinical cancer research. 1996, Vol 2, Num 7, pp 1115-1122, issn 1078-0432Article

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2ZISSEL, G; AULITZKY, W. E; LORENZ, J et al.Cancer immunology and immunotherapy. 1996, Vol 42, Num 2, pp 122-126, issn 0340-7004Article

Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia : results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemiaSCHÖNBOHN, H; SCHULER, M; KOLBE, K et al.Annals of hematology (Print). 1995, Vol 71, Num 4, pp 161-168, issn 0939-5555Article

Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantationTILG, H; NORDBERG, J; VOGEL, W et al.Transplantation. 1992, Vol 54, Num 1, pp 142-146, issn 0041-1337Article

Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease : report of a phase I trial in bone marrow transplant recipientsAULITZKY, W. E; SCHULZ, T. F; DIERICH, M. P et al.The Journal of infectious diseases. 1991, Vol 163, Num 6, pp 1344-1347, issn 0022-1899, 4 p.Article

Acute effects of single doses of recombinant interferon-γ on blood cell counts and lymphocyte subsets in patients with advanced renal cell cancerAULITZKY, W. E; AULITZKY, W; GASTL, G et al.Journal of interferon research. 1989, Vol 9, Num 4, pp 425-433, issn 0197-8357Article

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialSTÖLZEL, F; PFIRRMANN, M; SCHMITZ, N et al.Leukemia. 2011, Vol 25, Num 3, pp 420-428, issn 0887-6924, 9 p.Article

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cellsFANTA, S; SONNENBERG, M; SKORTA, I et al.Oncogene (Basingstoke). 2008, Vol 27, Num 31, pp 4380-4384, issn 0950-9232, 5 p.Article